Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-6

Renal cyst formation complicating ALK inhibitors

Xiaomin Niu, Heather A Wakelee, Shuchi Anand

Journal of Onco-Nephrology

Retricted access

Case report

First published 2019-7

A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma

Barbara M Parker, John V Parker, Anastasios Lymperopoulos [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2024-3

Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group

Beth Fisher, Ashley Meyer, Anastasia Brown [...]

Journal of Pediatric Hematology/Oncology Nursing

Free access

Review article

First published 2016-1

ALK inhibitors in non-small cell lung cancer: the latest evidence and developments

Ivana Sullivan, David Planchard

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2011-2

Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor

Allison E. Drew, Samer Al-Assaad, Violeta Yu [...]

Journal of Biomolecular Screening

Open access

Research article

First published 2023-9

Economic burden in patients with anaplastic lymphoma kinase ( ALK )-positive non-small cell lung cancer (NSCLC),with or without brain metastases,receiving first-line ALK inhibitors

Yanyu Wu, Kaili Ren, Yin Wan [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2018

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Tiziana Vavalà, Silvia Novello

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2019-6

Brigatinib: Novel ALK Inhibitor for Non–Small-Cell Lung Cancer

Sara A. Spencer, Angela C. Riley, Adia Matthew [...]

Annals of Pharmacotherapy

Open access

Case report

First published 2025-10

Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report

Sumra S. Chaudhry, D. Ross Camidge, Michael R. Clay [...]

Rare Tumors

Free access

Review article

First published 2016-5

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Ourania Romanidou, Lorenza Landi, Federico Cappuzzo [...]

Therapeutic Advances in Medical Oncology

Search results